T. Ikeda

1.1k total citations
29 papers, 889 citations indexed

About

T. Ikeda is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, T. Ikeda has authored 29 papers receiving a total of 889 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Pharmacology. Recurrent topics in T. Ikeda's work include Drug Transport and Resistance Mechanisms (6 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Peroxisome Proliferator-Activated Receptors (4 papers). T. Ikeda is often cited by papers focused on Drug Transport and Resistance Mechanisms (6 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Peroxisome Proliferator-Activated Receptors (4 papers). T. Ikeda collaborates with scholars based in Japan, Germany and United States. T. Ikeda's co-authors include Yutaka Okada, Hiroshi Tada, Goro Awaya, Shigeo Suzuki, Yuichi Sugiyama, Wataru Takasaki, Atsushi Kurihara, Toshihiko Komai, Nazar Farid and Katsunobu Hagihara and has published in prestigious journals such as Diabetes, Biochemical and Biophysical Research Communications and FEBS Letters.

In The Last Decade

T. Ikeda

29 papers receiving 851 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Ikeda Japan 15 317 233 231 202 106 29 889
Mark A. Milad United States 15 333 1.1× 175 0.8× 189 0.8× 126 0.6× 80 0.8× 24 966
Sara Moráis Portugal 10 252 0.8× 220 0.9× 388 1.7× 168 0.8× 66 0.6× 27 921
Barry Quart United States 15 244 0.8× 109 0.5× 139 0.6× 331 1.6× 376 3.5× 28 1.2k
S. Unger Germany 10 180 0.6× 257 1.1× 139 0.6× 137 0.7× 168 1.6× 19 724
S Matern Germany 23 605 1.9× 560 2.4× 260 1.1× 286 1.4× 29 0.3× 84 1.5k
Hans‐Ulrich Schulz Germany 23 695 2.2× 546 2.3× 102 0.4× 438 2.2× 37 0.3× 60 1.5k
Jean‐Pierre Cosyns Belgium 24 220 0.7× 119 0.5× 804 3.5× 468 2.3× 28 0.3× 59 2.3k
Muhammad Choudhury United States 19 233 0.7× 130 0.6× 39 0.2× 427 2.1× 52 0.5× 90 1.1k
Huaijun Zhu China 16 100 0.3× 99 0.4× 113 0.5× 197 1.0× 85 0.8× 60 772
Hamim Zahir United States 17 200 0.6× 181 0.8× 91 0.4× 219 1.1× 423 4.0× 52 1.3k

Countries citing papers authored by T. Ikeda

Since Specialization
Citations

This map shows the geographic impact of T. Ikeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Ikeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Ikeda more than expected).

Fields of papers citing papers by T. Ikeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Ikeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Ikeda. The network helps show where T. Ikeda may publish in the future.

Co-authorship network of co-authors of T. Ikeda

This figure shows the co-authorship network connecting the top 25 collaborators of T. Ikeda. A scholar is included among the top collaborators of T. Ikeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Ikeda. T. Ikeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tozuka, Zenzaburo, et al.. (2010). Microdose Study of 14C-Acetaminophen With Accelerator Mass Spectrometry to Examine Pharmacokinetics of Parent Drug and Metabolites in Healthy Subjects. Clinical Pharmacology & Therapeutics. 88(6). 824–830. 31 indexed citations
2.
3.
Hagihara, Katsunobu, Miho Kazui, Takashi Nanba, et al.. (2009). Comparison of formation of thiolactones and active metabolites of prasugrel and clopidogrel in rats and dogs. Xenobiotica. 39(3). 218–226. 30 indexed citations
4.
Nishiya, Yumi, Katsunobu Hagihara, Atsushi Kurihara, et al.. (2009). Comparison of mechanism-based inhibition of human cytochrome P450 2C19 by ticlopidine, clopidogrel, and prasugrel. Xenobiotica. 39(11). 836–843. 51 indexed citations
5.
IIO, Shouichiro, et al.. (2008). Flow visualization of vortex structure in a pulsed rectangular jet. Journal of Visualization. 11(2). 125–132. 12 indexed citations
6.
Katoh, Miki, Takeshi Sawada, Mitsutoshi Nakajima, et al.. (2007). Humanization of Excretory Pathway in Chimeric Mice with Humanized Liver. Toxicological Sciences. 97(2). 533–538. 56 indexed citations
7.
Nakai, Daisuke, et al.. (2007). Gemfibrozil and its glucuronide inhibit the hepatic uptake of pravastatin mediated by OATP1B1. Xenobiotica. 37(5). 474–486. 49 indexed citations
8.
Hagihara, Katsunobu, Atsushi Kurihara, Kenji Kawai, et al.. (2007). Absorption, distribution and excretion of the new thienopyridine agent prasugrel in rats. Xenobiotica. 37(7). 788–801. 9 indexed citations
9.
Shibayama, Takahiro, et al.. (2006). Renal handling of CS-023 (RO4908463), a novel parenteral carbapenem antibiotic, in rabbits in comparison with meropenem. Xenobiotica. 36(12). 1273–1287. 5 indexed citations
10.
Shibayama, Takahiro, et al.. (2006). Prediction of pharmacokinetics of CS-023 (RO4908463), a novel parenteral carbapenem antibiotic, in humans using animal data. Xenobiotica. 37(1). 91–102. 7 indexed citations
11.
Honda, Tadashi, Wataru Takasaki, T. Ikeda, et al.. (2001). A comparison of the effects of 3-hydroxy-3-methylglutaryl-coenzyme a (HMG-CoA) reductase inhibitors on the CYP3A4-dependent oxidation of mexazolam in vitro.. PubMed. 29(3). 282–8. 72 indexed citations
12.
Kawai, Kenji, et al.. (2000). Intestinal absorption and excretion of troglitazone sulphate, a major biliary metabolite of troglitazone. Xenobiotica. 30(7). 707–715. 7 indexed citations
13.
14.
Nishimura, Kazunobu, Katsuhiko Matsuda, Satoshi Konno, et al.. (1997). Beneficial effect of synthetic human atrial natriuretic polypeptide on renal function in a patient with giant atria. Journal of Thoracic and Cardiovascular Surgery. 113(4). 793–795. 8 indexed citations
15.
Ikeda, T., et al.. (1997). 2.P.90 Inhibition of hepatic cytochrome P450 isoform, CYP3A, by 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors. Atherosclerosis. 134(1-2). 135–135. 5 indexed citations
16.
Higami, Yoshikazu, Isao Shimokawa, Tomoaki Okimoto, & T. Ikeda. (1994). Vulnerability to oxygen radicals is more important than impaired repair in hepatocytic deoxyribonucleic acid damage in aging.. PubMed. 71(5). 650–6. 16 indexed citations
17.
Ikeda, T., Chohei Shigeno, Rinshi S. Kasai, et al.. (1993). Ovariectomy Decreases the mRNA Levels of Transforming Growth Factor-β1 and Increases the mRNA Levels of Osteocalcin in Rat Bone in Vivo. Biochemical and Biophysical Research Communications. 194(3). 1228–1233. 25 indexed citations
18.
Kozuka, Hiroshi, et al.. (1991). Characteristics of Peroxisome Proliferation: Co-induction of Peroxisomal Fatty Acid Oxidation-Related Enzymes with Microsomal Laurate Hydroxylase.. Chemical and Pharmaceutical Bulletin. 39(5). 1267–1271. 9 indexed citations
19.
Ohta, Shuichi, T. Yamamuro, Kyongbum Lee, et al.. (1991). Fracture healing induces expression of the proto‐oncogene c‐fos in vivo Possible involvement of the Fos protein in osteoblastic differentiation. FEBS Letters. 284(1). 42–45. 38 indexed citations
20.
Ikeda, T., Izumi C. Mori, Kuniaki Fukuda, et al.. (1988). Induction of Peroxisome Proliferation in Rat Liver by Dietary Treatment with 2,2,4,4,6,8,8-Heptamethylnonane. Xenobiotica. 18(11). 1271–1280. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark A. Milad Breakdown of academic impact, for papers by Sara Moráis Breakdown of academic impact, for papers by Barry Quart Breakdown of academic impact, for papers by S. Unger Breakdown of academic impact, for papers by S Matern Breakdown of academic impact, for papers by Hans‐Ulrich Schulz Breakdown of academic impact, for papers by Jean‐Pierre Cosyns Breakdown of academic impact, for papers by Muhammad Choudhury Breakdown of academic impact, for papers by Huaijun Zhu Breakdown of academic impact, for papers by Hamim Zahir
Rankless by CCL
2026